UW Today

Anna Wald

January 15, 2014

Data suggest new class of drug may be potent against genital herpes

herpes simplex virus

A new drug, called pritelivir, may offer a new treatment option for patients with genital herpes, a new industry-sponsored – study led by University of Washington researchers has found.

September 12, 2013

Initial positive results reported on vaccine to treat genital herpes

Scanning electron micrograph of a human T cells. The GEN-003 herpes vaccine candidate is designed to manipulate the immune responses of T cells, among other therapeutic effects.

The vaccine is the first to significantly reduce the frequency of viral shedding — the surfacing of herpes virus on the genitals — and appears to activate T cell immune responses to the virus.